Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,746,852
  • Shares Outstanding, K 254,810
  • Annual Sales, $ 91,250 K
  • Annual Income, $ -349,000 K
  • 60-Month Beta 1.54
  • Price/Sales 15.13
  • Price/Cash Flow N/A
  • Price/Book 5.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.26
  • Number of Estimates 7
  • High Estimate -0.21
  • Low Estimate -0.35
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +36.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.69 +24.12%
on 01/27/20
11.29 -4.52%
on 02/13/20
+0.99 (+10.17%)
since 01/21/20
3-Month
8.69 +24.12%
on 01/27/20
11.29 -4.52%
on 02/13/20
+1.32 (+13.95%)
since 11/21/19
52-Week
7.11 +51.62%
on 10/02/19
14.61 -26.24%
on 04/08/19
-0.47 (-4.18%)
since 02/21/19

Most Recent Stories

More News
Amicus Therapeutics to Announce Full-Year 2019 Financial Results on March 2, 2020

Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, March 2, 2020 at 8:30 a.m. ET to discuss financial results for the full...

FOLD : 10.78 (-0.46%)
Amicus Therapeut Rises 2.82% on Heavy Volume: Watch For Potential Pullback

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $10.44 to a high of $10.82. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high...

FOLD : 10.78 (-0.46%)
Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposium(TM) 2020

Amicus Therapeutics (Nasdaq: FOLD), a global, patient centric biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that one oral presentation...

FOLD : 10.78 (-0.46%)
Relatively Good Performance Detected in Shares of La Jolla Pharm in the Biotechnology Industry (LJPC , INSM , FOLD , GBT , PTLA )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

FOLD : 10.78 (-0.46%)
INSM : 31.25 (+2.69%)
LJPC : 8.12 (-1.58%)
Relatively Good Performance Detected in Shares of Akebia Therapeut in the Biotechnology Industry (AKBA , FOLD , NVTA , BPMC , CTMX )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AKBA : 10.15 (-0.88%)
FOLD : 10.78 (-0.46%)
NVTA : 23.10 (-3.02%)
Look for Shares of Amicus Therapeut to Potentially Rebound after Yesterday's 2.01% Sell Off

Amicus Therapeut (NASDAQ:FOLD) traded in a range yesterday that spanned from a low of $9.17 to a high of $9.55. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $9.23...

FOLD : 10.78 (-0.46%)
Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance

2020 Galafold Revenue Guidance of $250M-$260M

FOLD : 10.78 (-0.46%)
Costco, Amicus rise; Kohl's, Acuity fall

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:

COST : 321.95 (-0.66%)
KSS : 44.55 (-0.49%)
AYI : 115.70 (-0.13%)
FOLD : 10.78 (-0.46%)
CHS : 4.12 (-2.60%)
BBBY : 12.45 (-1.74%)
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance

Galafold Revenue of $181 Million for Full-Year 2019 and $54 Million in Q4 Reflects Continued Strong Adoption & Patient Adherence in All Key Global Regions

FOLD : 10.78 (-0.46%)
Amicus (FOLD) Provides Updates on AT-GAA for Pompe Disease

Amicus (FOLD) announces updates on its investigational therapy, AT-GAA, for Pompe disease.

AMRN : 17.93 (+0.34%)
FOLD : 10.78 (-0.46%)
AGEN : 3.52 (-7.12%)
AQB : 1.81 (+5.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade FOLD with:

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

2nd Resistance Point 10.95
1st Resistance Point 10.87
Last Price 10.78
1st Support Level 10.65
2nd Support Level 10.51

See More

52-Week High 14.61
Fibonacci 61.8% 11.75
Fibonacci 50% 10.86
Last Price 10.78
Fibonacci 38.2% 9.98
52-Week Low 7.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar